#Sweden #Stockholm #Iron Deficiency #Lactiplantibacillus #Probi AB

Biotic Innovation Revolutionizes Iron Absorption for Women

In recent years, the persistent issue of iron deficiency among women has drawn attention around the globe. With over 30% of reproductive-age women affected, the search for effective solutions is more urgent than ever. One innovative approach has come from Probi AB, a biotics solutions company based in Sweden, which has developed a groundbreaking health product aimed at addressing this widespread nutritional challenge.

The product utilizes a clinically studied probiotic strain known as Lactiplantibacillus plantarum 299v, or LP299V®. This unique strain not only promotes better iron absorption but also alleviates the gastrointestinal discomfort that often accompanies traditional iron supplements. As women worldwide grapple with the effects of iron deficiency, this advancement promises significant improvements to health outcomes.

LP299V® works effectively by maintaining iron in its absorbable form and enhancing the body’s production of enzymes that convert iron for easier uptake. This dual-action mechanism ensures that women can derive the maximum benefits from both dietary sources of iron and supplementation.

Moreover, the product's efficacy has gained global recognition, recently winning top honors across Europe, North America, and Asia. These accolades, including the NuIngredients-Asia Award for Innovation in Women's Health, underscore the scientific validation of LP299V® in combating iron deficiency on an international scale. Martina Pettersson, Global Marketing Director at Probi, noted that this recognition reflects the urgent need for effective solutions to a pressing global health issue.

The award presented in Bangkok on September 17th is particularly significant as it comes at a time when millions of women in Asia continue to face the adverse effects of iron deficiency. Karen Ong, Head of Asia-Pacific at Probi, highlighted the importance of accessible and well-tolerated health solutions in making a meaningful impact on women's health.

Founded in 1991 and born from research at Lund University, Probi aims to lead the charge in biotics solutions for health supplements, further expanding their mission to improve global health. Since joining Symrise AG in 2025, the company has fortified its innovation capabilities and broadened its reach, allowing it to serve over 40 markets worldwide, backed by multiple patents.

This biotic innovation represents a vital step toward addressing one of the most pervasive nutritional problems of our time. As Probi continues to push the boundaries through scientific research, the potential for transformational health benefits for women is immense, showcasing how advancements in the field of biotics can play a critical role in the global challenge of iron deficiency.

In conclusion, as awareness of iron deficiency and the need for effective supplementation grows, solutions like LP299V® could open new doors for millions of women seeking better health. The future looks promising as biotic innovations pave the way for healthier lives, underscoring the importance of continuous research and development in tackling pressing health issues.